| Autumn Kris Ann Beckman, | |
|
1015 W Washbourne St, Jay, OK 74346-4205 | |
| (918) 308-5513 | |
| (918) 253-6645 |
| Full Name | Autumn Kris Ann Beckman |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - General Practice |
| Location | 1015 W Washbourne St, Jay, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831877554 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WG0000X | Registered Nurse - General Practice | 223700 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Autumn Kris Ann Beckman, 1015 W Washbourne St, Jay, OK 74346-4205 Ph: (918) 308-5513 | Autumn Kris Ann Beckman, 1015 W Washbourne St, Jay, OK 74346-4205 Ph: (918) 308-5513 |
News Archive
Dutch researchers believe they may have come up with a new way of predicting whether patients with arthritic symptoms will progress to the autoimmune form of the disease, rheumatoid arthritis.
Rep. Bart Stupak, D-Mich., who is leading a coalition of anti-abortion Democrats standing in the way of party leadership efforts to pass a health bill, signaled Monday that the impasse may be close to resolution.
Biovail Corporation today provided an update on its Phase III program with pimavanserin for Parkinson's disease psychosis (PDP), which is being pursued in collaboration with ACADIA Pharmaceuticals Inc. Following the announcement on September 1st of disappointing top-line results from the first Phase III PDP trial, Biovail and ACADIA remain committed to the successful development of pimavanserin and have established a development strategy that they believe will strengthen the PDP program.
Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that it has received funding to advance an immunotherapy targeting WNT1-Inducible Signaling Protein-1 (WISP1) for the potential treatment of IPF, which affects more than 100,000 Americans.
› Verified 1 days ago
Katherine Anne Hollenbeck, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 859 E Melton Dr, Jay, OK 74346 Phone: 918-253-1738 | |
Holly Anne Marsh, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1015 W Washbourne St, Jay, OK 74346 Phone: 918-308-5513 Fax: 918-253-6645 | |
Kellsey Miner, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1015 W Washbourne St, Jay, OK 74346 Phone: 918-308-5513 | |
Emily Graham, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1015 W Washbourne St, Jay, OK 74346 Phone: 918-308-5513 | |
Haley Armbrister, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 859 E Melton Dr, Jay, OK 74346 Phone: 877-293-4271 | |
Kimberly Angel Blanton, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1015 W Washbourne St, Jay, OK 74346 Phone: 918-308-5513 Fax: 918-786-4435 | |
Amity Blythe Sparks, RN, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 859 E Melton Dr, Jay, OK 74346 Phone: 918-253-1761 |